CANADA PENSION PLAN INVESTMENT BOARD - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
CANADA PENSION PLAN INVESTMENT BOARD ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$3,208,000
+94.3%
137,906
+32.8%
0.01%
+100.0%
Q1 2018$1,651,000
-29.7%
103,806
-7.6%
0.00%
-25.0%
Q4 2017$2,348,000
+297.3%
112,306
+171.9%
0.00%
+300.0%
Q3 2017$591,000
-98.4%
41,306
-98.0%
0.00%
-98.8%
Q2 2017$36,525,000
+39174.2%
2,104,500
+24953.6%
0.08%
Q1 2017$93,0008,400
+83900.0%
0.00%
Q4 2016$0
-100.0%
10
-99.8%
0.00%
Q3 2016$115,000
-87.4%
4,710
-89.7%
0.00%
-100.0%
Q2 2016$913,000
-3.4%
45,510
+26.7%
0.00%0.0%
Q1 2016$945,000
-91.3%
35,910
-67.1%
0.00%
-92.2%
Q4 2015$10,914,000
-92.3%
109,072
-86.3%
0.05%
-91.2%
Q3 2015$141,153,000
-8.2%
794,472
+14.8%
0.58%
+15.5%
Q2 2015$153,770,000
-0.6%
691,872
-11.6%
0.50%
-12.2%
Q1 2015$154,636,000
+30.9%
782,727
-4.8%
0.57%
+50.9%
Q4 2014$118,104,000
+41.3%
822,427
+29.2%
0.38%
+29.4%
Q3 2014$83,572,000
+6.8%
636,427
+3.0%
0.29%
+8.1%
Q2 2014$78,247,000
+4.3%
617,644
+8.4%
0.27%
-9.1%
Q1 2014$75,053,000
+96.4%
569,579
+74.8%
0.30%
+92.3%
Q4 2013$38,208,000
-70.6%
325,761
-73.8%
0.16%
-73.4%
Q3 2013$130,145,000
+839.1%
1,245,591
+672.6%
0.58%
+743.5%
Q2 2013$13,859,000
-17.2%
161,230
-27.7%
0.07%
-20.7%
Q1 2013$16,733,000222,9170.09%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2013
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders